Swedish Healthtech Stock News

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Key Insights The considerable ownership by private companies in Fastighets AB Balder indicates that they collectively...

The European market has shown resilience, with the STOXX Europe 600 Index gaining ground thanks to robust economic data and encouraging earnings results. Amid this backdrop, penny stocks—though often associated with speculative trading—remain a relevant investment area when backed by solid financials. These smaller or newer companies can offer a unique blend of affordability and growth potential, making them attractive options for investors seeking opportunities beyond the mainstream.

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Cheffelo's (STO:CHEF) stock is up by a considerable 24% over the past month. As most would know, fundamentals are what...

Key Insights Significant control over Volati by individual investors implies that the general public has more power to...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Invisio fair value estimate is kr403 Invisio's kr313 share...

Key Insights Lifco's significant insider ownership suggests inherent interests in company's expansion The largest...

To the annoyance of some shareholders, Acuvi AB ( STO:ACUVI ) shares are down a considerable 26% in the last month...

Gruvaktiebolaget Viscaria ( STO:VISC ) shareholders are no doubt pleased to see that the share price has bounced 41% in...

Camurus AB (publ) recently announced that the U.S. FDA has accepted for review its resubmitted New Drug Application for Oclaiz (CAM2029), an extended-release octreotide injection for acromegaly, with a PDUFA target action date set for 10 June 2026. This acceptance helps clear a prior hurdle tied to third-party manufacturing observations and follows earlier EU and UK approvals and launch of the same product, marketed there as Oczyesa. We will now examine how FDA acceptance of the Oclaiz...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") below 22x, you may consider Sweco...

Investment AB Latour (publ) ( STO:LATO B ) saw significant share price movement during recent months on the OM, rising...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Why Nobia’s rights issue and UK exit matter for shareholders Nobia (OM:NOBI) is overhauling its business by selling its UK operations, refocusing on Nordic markets, and raising approximately SEK 1.5b through a rights issue, together with new loan agreements and planned capital structure changes. See our latest analysis for Nobia. The rights issue, UK exit and refinancing have come against a weak share price backdrop, with a 7 day share price return of 27.12% decline and a 5 year total...

Truecaller (OM:TRUE B) has completed another round of share repurchases, taking treasury holdings to 5.02%, with the buyback programme timed ahead of the company’s 2026 Annual General Meeting. See our latest analysis for Truecaller. Despite the latest buybacks, the share price has come under pressure, with a 1 day share price return of a 2.96% decline, a 7 day share price return of a 9.94% decline and a 90 day share price return of a 57.88% decline. The 1 year total shareholder return of a...

Despite an already strong run, Ferroamp AB (publ) ( STO:FERRO ) shares have been powering on, with a gain of 26% in the...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") below 22x, you may consider ASSA...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Investors who take an interest in Case Group AB (publ) ( STO:CASE ) should definitely note that the Independent...

Betsson AB (publ) ( STO:BETS B ) shareholders that were waiting for something to happen have been dealt a blow with a...

With a price-to-earnings (or "P/E") ratio of 19.2x Holmen AB (publ) ( STO:HOLM B ) may be sending bullish signals at...